ABVC BioPharma Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for ABVC BioPharma.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for ABVC BioPharma.

Recommendation Trends

Rating	Nov '22
Strong Buy	0
Buy	0
Hold	0
Sell	0
Strong Sell	0
Total	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 16, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 152.43K

Revenue Next Year

4.26M

EPS This Year

-0.45

from -2.43

EPS Next Year

-0.47

from -0.45

Year	2019	2020	2021	2022	2023	2024	2025
Revenue	701.72K	483.05K	355.80K	969.78K	152.43K	-	4.26M
Revenue Growth	-	-31.16%	-26.34%	172.57%	-84.28%	-	-
EPS	-2.10	-5.00	-5.10	-5.19	-2.43	-0.45	-0.47
EPS Growth	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025
High	n/a	4.4M
Avg	n/a	4.3M
Low	n/a	4.1M

Revenue Growth

Revenue Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2024	2025
High	-0.46	-0.48
Avg	-0.45	-0.47
Low	-0.43	-0.45

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.